The South African health products Regulatory Authority said on the 7th that the new crown vaccine of China National Pharmaceutical Group has been approved for official use in the country. In addition, according to the announcement of the food and Drug Administration of Thailand, it has been approved to expand the vaccination scope of China Kexing and Sinopharm Xinguan vaccine to people aged 6 and over. The South African health products Regulatory Authority said on the 7th that Sinopharm Xinguan vaccine has been approved to be officially used in South Africa for vaccination of people aged 18 and over. South Africa is the most serious country in Africa COVID-19. Last July, the new coronavirus vaccine produced by China's Kexing company was approved for emergency use in South Africa. According to the data of the National Institute of infectious diseases of South Africa, as of February 7, there were 3625190 newly diagnosed cases and 96021 deaths in South Africa; About 16.61 million adults in the country have completed the whole process of vaccination against the new coronavirus vaccine, accounting for about 41.74% of the total adult population. The Chinese Embassy in South Africa welcomed the registration of Sinopharm coronavirus vaccine in South Africa on the 8th. In a statement released on the same day, the embassy said that with the joint efforts of the international community, important progress has been made in the global fight against the epidemic, but the epidemic has been repeatedly delayed, the virus has increased mutation and the transmission speed has accelerated, posing a serious threat to the lives and safety of people in all countries. The Chinese Embassy in South Africa will continue to actively implement the solemn commitment of China's vaccine to become a global public product, and fully assist the people of South Africa and Africa to fight and finally overcome the epidemic. According to the announcement recently issued by the food and Drug Administration of Thailand, China Kexing and Sinopharm Xinguan vaccines were approved for emergency vaccination in Thailand for people aged 18 and over in 2021. At the end of last year, the Bureau began to examine the application for expanding the vaccination scope of Kexing and Sinopharm Xinguan. After a comprehensive assessment of the quality, safety and effectiveness of the two vaccines, the Bureau approved the vaccination of the two vaccines among people aged 6 to 17. (Xinhua News Agency)